Table 1.
HPV Vaccine Reimbursement by Private Payer Across Clinician Specialties, 2017-2018
| Measure | Clinician Specialty | ||||
|---|---|---|---|---|---|
| Pediatrician n = 20,484 |
Family Physician n = 9,342 |
Internal Medicine Specialist n = 852 |
Nurse Practitioner n = 2,339 |
Other n = 1,230 |
|
| HPV vaccine reimbursement, mean (SD)a | $216.07 ($8.53) | $211.33c ($16.80) | $212.97c ($14.70) | $212.91c ($14.74) | $213.29c ($14.17) |
| Net return per dose, mean (SD)b | $5.08 ($8.53) | $0.34 ($16.80) | $1.98 ($14.70) | $1.92 ($14.74) | $2.30 ($14.17) |
AAP = American Academy of Pediatrics; CDC = Centers for Disease Control and Prevention; HPV = human papillomavirus vaccine.
a
HPV vaccine reimbursement was calculated as the dollar amount paid for the HPV vaccine cost to the clinician by the insurer.
b
In 2017-2018, the CDC recommended pricing per HPV vaccine dose for the private sector was $210.99. Recommended vaccine purchase reimbursement and immunization incentive by the AAP is 125% ($263.74) of the CDC vaccine price list for the private sector.
c
P <0.05 for the Kruskal-Wallis post hoc test compared with pediatricians.